Lysophosphatidic acid upregulates the epidermal growth factor receptor in human airway smooth muscle cells

Tracy L. Ediger, Bryan L. Danforth, Myron Lee Toews

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Human airway smooth muscle cells treated with lysophos-phatidic acid (LPA) and epidermal growth factor (EGF) exhibit synergistic stimulation of mitogenesis (Ediger TL and Toews ML. J Pharmacol Exp Ther 294: 1076-1082, 2000). The effects of LPA treatment of human airway smooth muscle cells on EGF receptor (EGFR) regulation have now been investigated. LPA treatment for 12-24 h resulted in a two-fold increase in 125I-EGF binding and EGFR protein levels as assessed by Western blot analysis. Competition binding as-says indicated single-site binding with an affinity of 3 nM, and the affinity was not changed by LPA treatment. EGFR upregulation was blocked by cycloheximide and actinomycin D, suggesting that LPA influences transcriptional regulation of EGFR expression. Inhibitor studies revealed a prominent role for activation of mitogen-activated protein kinase and p70 ribosomal S6 kinase. Both synergism and EGFR upregulation increased with increased cell density, whereas EGFR expression in control cells decreased. The similar requirements for exposure time, LPA concentrations, and cell confluence suggest that EGFR upregulation may be one contributing factor to the synergistic stimulation of mitogenesis seen with LPA plus EGF.

Original languageEnglish (US)
Pages (from-to)L91-L98
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume282
Issue number1 26-1
StatePublished - Jun 29 2002

Fingerprint

Epidermal Growth Factor Receptor
Smooth Muscle Myocytes
Up-Regulation
Acids
Epidermal Growth Factor
70-kDa Ribosomal Protein S6 Kinases
Dactinomycin
Cycloheximide
lysophosphatidic acid
Mitogen-Activated Protein Kinases
Cell Count
Western Blotting
Binding Sites
Proteins

Keywords

  • Airway remodeling
  • Epidermal growth factor receptor regulation
  • Proliferation
  • Synergism

ASJC Scopus subject areas

  • Physiology
  • Pulmonary and Respiratory Medicine
  • Physiology (medical)
  • Cell Biology

Cite this

Lysophosphatidic acid upregulates the epidermal growth factor receptor in human airway smooth muscle cells. / Ediger, Tracy L.; Danforth, Bryan L.; Toews, Myron Lee.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 282, No. 1 26-1, 29.06.2002, p. L91-L98.

Research output: Contribution to journalArticle

@article{6bdd2fe7732e4198a63db6aecc75ed25,
title = "Lysophosphatidic acid upregulates the epidermal growth factor receptor in human airway smooth muscle cells",
abstract = "Human airway smooth muscle cells treated with lysophos-phatidic acid (LPA) and epidermal growth factor (EGF) exhibit synergistic stimulation of mitogenesis (Ediger TL and Toews ML. J Pharmacol Exp Ther 294: 1076-1082, 2000). The effects of LPA treatment of human airway smooth muscle cells on EGF receptor (EGFR) regulation have now been investigated. LPA treatment for 12-24 h resulted in a two-fold increase in 125I-EGF binding and EGFR protein levels as assessed by Western blot analysis. Competition binding as-says indicated single-site binding with an affinity of 3 nM, and the affinity was not changed by LPA treatment. EGFR upregulation was blocked by cycloheximide and actinomycin D, suggesting that LPA influences transcriptional regulation of EGFR expression. Inhibitor studies revealed a prominent role for activation of mitogen-activated protein kinase and p70 ribosomal S6 kinase. Both synergism and EGFR upregulation increased with increased cell density, whereas EGFR expression in control cells decreased. The similar requirements for exposure time, LPA concentrations, and cell confluence suggest that EGFR upregulation may be one contributing factor to the synergistic stimulation of mitogenesis seen with LPA plus EGF.",
keywords = "Airway remodeling, Epidermal growth factor receptor regulation, Proliferation, Synergism",
author = "Ediger, {Tracy L.} and Danforth, {Bryan L.} and Toews, {Myron Lee}",
year = "2002",
month = "6",
day = "29",
language = "English (US)",
volume = "282",
pages = "L91--L98",
journal = "American Journal of Physiology - Renal Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "1 26-1",

}

TY - JOUR

T1 - Lysophosphatidic acid upregulates the epidermal growth factor receptor in human airway smooth muscle cells

AU - Ediger, Tracy L.

AU - Danforth, Bryan L.

AU - Toews, Myron Lee

PY - 2002/6/29

Y1 - 2002/6/29

N2 - Human airway smooth muscle cells treated with lysophos-phatidic acid (LPA) and epidermal growth factor (EGF) exhibit synergistic stimulation of mitogenesis (Ediger TL and Toews ML. J Pharmacol Exp Ther 294: 1076-1082, 2000). The effects of LPA treatment of human airway smooth muscle cells on EGF receptor (EGFR) regulation have now been investigated. LPA treatment for 12-24 h resulted in a two-fold increase in 125I-EGF binding and EGFR protein levels as assessed by Western blot analysis. Competition binding as-says indicated single-site binding with an affinity of 3 nM, and the affinity was not changed by LPA treatment. EGFR upregulation was blocked by cycloheximide and actinomycin D, suggesting that LPA influences transcriptional regulation of EGFR expression. Inhibitor studies revealed a prominent role for activation of mitogen-activated protein kinase and p70 ribosomal S6 kinase. Both synergism and EGFR upregulation increased with increased cell density, whereas EGFR expression in control cells decreased. The similar requirements for exposure time, LPA concentrations, and cell confluence suggest that EGFR upregulation may be one contributing factor to the synergistic stimulation of mitogenesis seen with LPA plus EGF.

AB - Human airway smooth muscle cells treated with lysophos-phatidic acid (LPA) and epidermal growth factor (EGF) exhibit synergistic stimulation of mitogenesis (Ediger TL and Toews ML. J Pharmacol Exp Ther 294: 1076-1082, 2000). The effects of LPA treatment of human airway smooth muscle cells on EGF receptor (EGFR) regulation have now been investigated. LPA treatment for 12-24 h resulted in a two-fold increase in 125I-EGF binding and EGFR protein levels as assessed by Western blot analysis. Competition binding as-says indicated single-site binding with an affinity of 3 nM, and the affinity was not changed by LPA treatment. EGFR upregulation was blocked by cycloheximide and actinomycin D, suggesting that LPA influences transcriptional regulation of EGFR expression. Inhibitor studies revealed a prominent role for activation of mitogen-activated protein kinase and p70 ribosomal S6 kinase. Both synergism and EGFR upregulation increased with increased cell density, whereas EGFR expression in control cells decreased. The similar requirements for exposure time, LPA concentrations, and cell confluence suggest that EGFR upregulation may be one contributing factor to the synergistic stimulation of mitogenesis seen with LPA plus EGF.

KW - Airway remodeling

KW - Epidermal growth factor receptor regulation

KW - Proliferation

KW - Synergism

UR - http://www.scopus.com/inward/record.url?scp=0036082970&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036082970&partnerID=8YFLogxK

M3 - Article

C2 - 11741820

AN - SCOPUS:0036082970

VL - 282

SP - L91-L98

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 0363-6127

IS - 1 26-1

ER -